Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
NCT00227136
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Carcinoid Tumors
Neuroendocrine Tumors
Interventions
DRUG:
5-Hydroxy-Tryptamine
Sponsor
University of Western Ontario, Canada